Metraipolis › archive › dc_be67da3e46b4
Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty — Europe PMC PMID:41623908
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41623908
- DOI
- 10.1210/jendso/bvaf224
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T10:13:11.827Z
- SHA-256 of the archived text
4a46af672b23325114d8615196dbfea368b2f1a54d24494198bf61984e8f23a9- Stable URL of this page
https://metraipolis.com/documento/dc_be67da3e46b4
How to cite
Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty — Europe PMC PMID:41623908 — Europe PMC (en), https://europepmc.org/article/MED/41623908 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be67da3e46b4 (Metraipolis archive dc_be67da3e46b4, sha256 4a46af672b23325114d8615196dbfea368b2f1a54d24494198bf61984e8f23a9)
BibTeX
@misc{dcbe67da3e46b4,
title = {Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty — Europe PMC PMID:41623908},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41623908},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be67da3e46b4; sha256 4a46af672b23325114d8615196dbfea368b2f1a54d24494198bf61984e8f23a9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41623908. Agents can read the archived copy with the MCP tool read_document.